Transcranial Magnetic Stimulation (TMS) can be an effective and even lifechanging treatment. Although research suggests it is an effective treatment for various types of mental health and neurological disorders, most insurance companies presently authorize TMS only for those with “treatment resistant” depression. “Treatment resistant” refers to those who have attempted medication treatment and/or individual psychotherapy (i.e., “talk therapy” / counseling), yet still suffer.
Please complete the following information & Dr. Blair will go through more details during your consultation.
Please Select Current Symptoms
Substance Abuse History
Most insurance companies require a minimum of 3 antidepressant trials and somerequire at least 1 augmentation therapy (*) SSRI: Selective Serotonin Reuptake Inhibitor / SNRI: Serotonin-Norepinephrine Reuptake Inhibitors / SM: Serotonin Modulators / NDRI: Norepinephrine-Dopamine Reuptake Inhibitors / TeCA: Tetracyclic Antidepressants / MAOI: Monoamine Oxidase Inhibitors / TCA: Tricyclic Antidepressants
*Augmentation therapy is defined as any of the following:1) Two antidepressants with different mechanisms of action used at the same time (e.g., SSRI + NDRI).2) An antidepressant and a second-generation antipsychotic used at the same time.3) An antidepressant and Lithium or Lamictal (lamotrigine) used at the same time.4) An antidepressant and thyroid hormone used at the same time.5) An antidepressant and BuSpar (buspirone) used at the same time.6) An antidepressant and a stimulant (ADHD medication) used at the same time